Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know?
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
G. Aubertin, M. Boule, M. C. La Rocca, A. Clement, B. Fauroux (Paris, France). Daytime predictors of nocturnal hypoventilation in children with cystic fibrosis. Eur Respir J 2007; 30: Suppl. 51, 354

Member's Comments

No comment yet.

Related content which might interest you: Obstructive sleep apnea and nocturnal hypoventilation in adults and children with cystic fibrosis Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep Year: 2008 Measures of nocturnal oxyhemoglobin desaturation in children with obstructive lung disease or sleep-disordered breathing Source: International Congress 2018 – Improvements in the assessment of paediatric physiology Year: 2018 Sleep hypoxemia in cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 619s Year: 2005 Sleep quality and daytime function in adults with cystic fibrosis and severe lung disease Source: Eur Respir J 2002; 19: 504-510 Year: 2002 Prevalance of daytime hypercapnia in patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 574s Year: 2002 Correlations between severity of nocturnal hypoxemia and level of Galectin-3 in obstructive sleep apnea patients Source: International Congress 2019 – Consequences of sleep-disordered breathing from molecular and clinical points of view Year: 2019 Sleep-related breathing disturbances in idiopathic pulmonary fibrosis Source: Virtual Congress 2021 – The different faces of sleep disturbances in respiratory diseases and beyond Year: 2021 Obesity and daytime somnolence at patients with obstructive sleep apnea and sistemic hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 562s Year: 2002 Predictors of nocturnal desaturation in COPD patients with mild daytime hypoxaemia Source: Eur Respir J 2003; 22: Suppl. 45, 468s Year: 2003 Correlation between intermittent nocturnal hypercapnia and depressive symptoms in patients with obstructive sleep apnea syndrome Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity Year: 2011 Early onset of sleep-disordered breathing in patients with cystic fibrosis Source: Annual Congress 2010 - Lung disease and mountain sickness: the importance of ventilatory control Year: 2010 Nocturnal intermitent hypoxemia in patients with pulmonary hypertension and sleep apnea hypopnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 657s Year: 2006 CPAP therapy in idiopathic pulmonary fibrosis patients with obstructive sleep apnea Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity Year: 2011 OSA syndrome in children Source: Eur Respir Mon 2010; 50: 104-120 Year: 2010 Albuminuria in children with obstructive sleep apnea Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism Year: 2011 Pericardial effusion in patients with obstructive sleep apnea syndrome without daily hypoxemia and pulmonary arterial hypertension Source: International Congress 2016 – Comorbid sleep apnoea in specific clinical entities and differential diagnosis of sleep disorders Year: 2016 Daytime hypoxemia in obstructive sleep apnoea (OSA) subjects before CPAP therapy Source: Annual Congress 2009 - Clinical aspects of sleep apnoea Year: 2009 The prevalance of bronchial hyperreactivity in patients with habitual snoring and obstructive sleep apnea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 495s Year: 2002 Daytime hypercapnia in patients with obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2002; 20: Suppl. 38, 493s Year: 2002 Severity of sleep-disordered breathing is an independent predictor of metabolic dysfunction in a population with obstructive sleep apnoea Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011